NovoCure Ltd financial data

Symbol
NVCR on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
No. 4 The Forum, Grenville Street, St. Helier, Jersey
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Jul 25, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 628 % -14%
Quick Ratio 23.7 % +17.4%
Debt-to-equity 213 % +24.7%
Return On Equity -45.7 % -13.6%
Return On Assets -14.6 % +1.68%
Operating Margin -33.7 % +10.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 108M shares +1.5%
Common Stock, Shares, Outstanding 108M shares +1.32%
Entity Public Float 1.42B USD -50%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 108M shares +1.33%
Weighted Average Number of Shares Outstanding, Diluted 108M shares +1.33%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 550M USD +8.33%
Cost of Revenue 133M USD +8.77%
Research and Development Expense 214M USD -3.35%
Selling and Marketing Expense 229M USD +14.1%
General and Administrative Expense 159M USD +3.44%
Operating Income (Loss) -185M USD +2.85%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -141M USD +12.3%
Income Tax Expense (Benefit) 27.6M USD +106%
Net Income (Loss) Attributable to Parent -169M USD +3.25%
Earnings Per Share, Basic -1.58 USD/shares +4.24%
Earnings Per Share, Diluted -1.58 USD/shares +4.24%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 165M USD +4.98%
Accounts Receivable, after Allowance for Credit Loss, Current 64.7M USD -8.85%
Inventory, Net 40.4M USD +22.5%
Assets, Current 1.09B USD +2.57%
Property, Plant and Equipment, Net 66.5M USD +61.5%
Operating Lease, Right-of-Use Asset 29.1M USD +10.6%
Other Assets, Noncurrent 12.1M USD -17.2%
Assets 1.21B USD +4.59%
Employee-related Liabilities, Current 51M USD +25.2%
Contract with Customer, Liability, Current 15.6M USD
Liabilities, Current 169M USD +12.7%
Long-term Debt and Lease Obligation 0 USD -100%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 21.7M USD +6.9%
Other Liabilities, Noncurrent 18K USD -84.9%
Liabilities 850M USD +14.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.52M USD -77.4%
Retained Earnings (Accumulated Deficit) -1.06B USD -19%
Stockholders' Equity Attributable to Parent 362M USD -13%
Liabilities and Equity 1.21B USD +4.59%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -67.2M USD -224%
Net Cash Provided by (Used in) Financing Activities 90.6M USD +346%
Net Cash Provided by (Used in) Investing Activities -12.5M USD +94.1%
Common Stock, Shares, Issued 108M shares +1.32%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 10.9M USD -891%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 168M USD +6.95%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.97M USD +9833%
Deferred Tax Assets, Valuation Allowance 375M USD +3.88%
Deferred Tax Assets, Gross 386M USD +4.19%
Operating Lease, Liability 35.6M USD +45.1%
Payments to Acquire Property, Plant, and Equipment 37.3M USD +48.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -170M USD +2.3%
Lessee, Operating Lease, Liability, to be Paid 42.3M USD +49%
Property, Plant and Equipment, Gross 79.4M USD +41.2%
Operating Lease, Liability, Current 8.22M USD +41.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.13M USD +54.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.75M USD +40.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.7M USD +74.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.56M USD +46.3%
Deferred Tax Assets, Operating Loss Carryforwards 99.7M USD +52.3%
Unrecognized Tax Benefits 18K USD -76.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.32M USD +30.1%
Additional Paid in Capital 1.42B USD +8.9%
Deferred Tax Assets, Net of Valuation Allowance 10.7M USD +16.6%
Share-based Payment Arrangement, Expense 110M USD -14.2%